Skip to Main Content
American Flag
MEMORIAL DAY API SALE

50% off your first year of Quiver API

...

Use Promo Code:

MEM50
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

$IMRX stock is up 31% today. Here's what we see in our data.

None

$IMRX stock has now risen 31% today, according to our price data from Polygon. There has been approximately $26,837,800 of trading volume.

It has been the 276th most-searched ticker on Quiver Quantitative over the last day, out of 13,833 total tickers searched.

Here is what we see in our data on $IMRX (you can track the company live on Quiver's $IMRX stock page):

$IMRX Insider Trading Activity

IMRX Insider Trades

$IMRX insiders have traded $IMRX stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $IMRX stock by insiders over the last 6 months:

  • THOMAS J. SCHALL purchased 21,645 shares for an estimated $101,041
  • PETER FEINBERG purchased 20,000 shares for an estimated $86,904
  • HAROLD EUGENE BRAKEWOOD (Chief Business Officer) purchased 5,250 shares for an estimated $24,990
  • LEAH R NEUFELD (CHIEF PEOPLE OFFICER) purchased 2,626 shares for an estimated $10,905
  • BRETT MATTHEW HALL (CHIEF SCIENTIFIC OFFICER) purchased 2,298 shares for an estimated $10,501

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$IMRX Hedge Fund Activity

We have seen 58 institutional investors add shares of $IMRX stock to their portfolio, and 50 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS
Receive IMRX Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$IMRX Analyst Ratings

Wall Street analysts have issued reports on $IMRX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Chardan Capital issued a "Buy" rating on 05/19/2026

To track analyst ratings and price targets for $IMRX, check out Quiver Quantitative's $IMRX forecast page.

$IMRX Price Targets

Multiple analysts have issued price targets for $IMRX recently. We have seen 2 analysts offer price targets for $IMRX in the last 6 months, with a median target of $15.5.

Here are some recent targets:

  • Geulah Livshits from Chardan Capital set a target price of $20.0 on 05/19/2026
  • Ami Fadia from Needham set a target price of $11.0 on 03/09/2026

You can track data on $IMRX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles